The CureHeart Team in Oxford host major BHF donors SkyBet
On Monday (19th May) the CureHeart teams in Oxford welcomed delegates from BHF, and their partners SkyBet and Flutter to the John Radciffe Hospital for a day of talks, lab tours and networking. CureHeart Scientific director Hugh Watkins and BHF Chief Executive Charmaine Griffiths both shared their vision and commitment to finding a translational genetic therapy for inherited heard conditions. Our team of researchers were then excited to share their individual work on understanding, diagnosing and modelling inherited cardiomyopathies, as well as developing state of the art treatments and delivering them to the heart, to stop the disease in its tracks. The day culminated in a series of lab tours to the clinical diagnostic and imaging facilities, molecular biology labs and tissue culture suites to see our experiments in action. SkyBet were eager to learn about the work and engaged with our team. The commitment of SkyBet as the BHF’s commercial partner, has enabled the CureHeart team to think big and drive innovation for the future benefit of all of those affected by inherited heart disorders. Everybody at CureHeart would like to thank them for their support.
